Form D — DalCor Pharmaceuticals US, LLC
0001231919-26-001113 · filed Aug 28, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $6,958,236
- Total sold
- $6,958,236
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- DalCor Pharmaceuticals US, LLC
- CIK
- 1673368
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 677 North Washington Blvd
Sarasota, FL 34236 - Phone
- 514 508-5099
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Douglas Michael Dixon · DirectorSarasota, FL Find on LinkedIn ↗
-
Paul Fonteyne · DirectorSarasota, FL Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗